Company profile
InMed Pharmaceuticals Inc. Insider Trading
INMEvery SEC Form 4 insider trading filing for InMed Pharmaceuticals Inc. (INM) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001728328
- Filings
- 55
- Insiders
- 19
- Last filing
- 2026-09-16
Activity summary
Recent insider activity is bullish. Over the last 30 days, 3 insiders purchased shares (net $118K). Buying was led by ADAR1 Capital Management, LLC.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. InMed Pharmaceuticals Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.1M.
90 day insight
Over the last 90 days, InMed Pharmaceuticals Inc. insiders bought $162K across 16 transactions with no open-market sales.
- Most active insider: Vivo Opportunity, LLC with 12 transactions totaling $42K.
- Largest single purchase: $70K by ADAR1 Capital Management, LLC on Sep 15, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | ADAR1 Capital Management, LLC | INM | Purchase | 8,340 | $1.29 | $11K |
| Sep 15, 2026 | ADAR1 Capital Management, LLC | INM | Purchase | 54,256 | $1.30 | $70K |
| Sep 14, 2026 | ADAR1 Capital Management, LLC | INM | Purchase | 28,505 | $1.29 | $37K |
| Jul 16, 2026 | Vivo Opportunity, LLC | INM | Purchase | 2 | $1.55 | $3 |
| Jul 16, 2026 | Vivo Opportunity, LLC | INM | Purchase | 19 | $1.55 | $29 |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=INM" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of InMed Pharmaceuticals Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →